|
|
|
Corporate Profile: Cangene
| Summary: |
Cangene is focused on the development and commercialization of immune therapies for infectious disease and biodefense. |
| Address (HQ): |
155 Innovation Drive
Winnipeg, MB
R3T 5Y3
Canada |
| Phone
#'s (HQ): |
| Main |
(204) 275-4200 |
| Human
Resources |
not known |
| Investor
Relations |
(416) 675-8280 |
| Fax
#'s (HQ): |
| Main |
(204) 269-7003 |
| Human
Resources |
(204) 275-4021 |
| Investor
Relations |
(416) 675-8301 |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
